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Abstract
 
The 
 
rae28
 
 gene (
 
rae28
 
), also designated as 
 
mph1
 
, is a mammalian ortholog of the 
 
Drosophila
polyhomeotic
 
 gene, a member of 
 
Polycomb
 
 group genes (
 
Pc
 
G). rae28 constitutes PcG complex 1
for maintaining transcriptional states which have been once initiated, presumably through
modulation of the chromatin structure. Hematopoietic activity was impaired in the fetal liver
 
of 
 
rae28
 
-deficient animals (
 
rae28
 
 
 
/
 
 
 
), as demonstrated by progressive reduction of hematopoietic
progenitors of multilineages and poor expansion of colony forming units in spleen (CFU-S
 
12
 
)
during embryonic development. An in vitro long-term culture-initiating cell assay suggested a
reduction in hematopoietic stem cells (HSCs), which was confirmed in vivo by reconstitution
experiments in lethally irradiated congenic recipient mice. The competitive repopulating units
(CRUs) reflect HSCs supporting multilineage blood-cell production. CRUs were generated,
 
whereas the number of CRUs was reduced by a factor of 20 in the 
 
rae28
 
 
 
/
 
 
 
 fetal liver. We also
performed serial transplantation experiments to semiquantitatively measure self-renewal activity
of CRUs in vivo. Self-renewal activity of CRUs was 15-fold decreased in 
 
rae28
 
 
 
/
 
 
 
. Thus the
compromised HSCs were presumed to reduce hematopoietic activity in the 
 
rae28
 
 
 
/
 
 
 
 fetal
liver. This is the first report to suggest that 
 
rae28
 
 has a crucial role in sustaining the activity of
HSCs to maintain hematopoiesis.
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Introduction
 
The 
 
Polycomb
 
 group genes (
 
Pc
 
G)
 
*
 
 were originally identified
from 
 
Drosophila
 
 mutants with impaired anteroposterior pat-
terning which is elicited by ectopic 
 
homeotic complex
 
(
 
HOMC
 
) expression. Spatial regulation of 
 
HOMC
 
 genes in
these mutants is correctly initiated, but it is not maintained
properly, indicating that 
 
Pc
 
G are required, not for the initi-
ation of transcription, but for the maintenance of repression
(1–3). PcG products form multimeric protein complexes
and epigenetically maintain the repressed state through mi-
tosis. 
 
Pc
 
G are conserved from 
 
Drosophila
 
 to mammals. The
 
rae28
 
 gene (
 
rae28
 
) is a mammalian homologue of the 
 
Dro-
sophila
 
 
 
polyhomeotic
 
 gene, which is a member of 
 
Pc
 
G (4, 5).
Mammalian PcG protein complexes can be classified into
two distinct sets of complexes, Polycomb complex 1 and 2
(6). rae28 is a constituent of Polycomb complex 1 with
M33, bmi1 or mel18, and Scmh1 (7–10). 
 
Drosophila
 
 Poly-
comb repressive complex 1, which possibly corresponds to
mammalian PcG complex 1, have an ability to competi-
tively inhibit chromatin remodeling complex, SWI/SNF
(11), and also interacts with 
 
 
 
30 proteins including general
transcription factors, sequence specific-DNA binding fac-
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Abbreviations used in this paper:
 
 BFU-E, erythroid burst-forming unit;
CFU-C, CFU culture; CFU-E, erythroid CFU; CFU-GM, granulocyte/
macrophage CFU; CFU-Mix, multilineage CFU; CFU-S
 
12
 
, day-12 CFU
spleen; CRU, competitive repopulating unit; dpc, d post coitus; HDAC,
histone deacetylase; HSC, hematopoietic stem cell; LTC-IC, long-term
culture-initiating cell; 
 
Pc
 
G, 
 
Polycomb
 
 group. 
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tor, zeste, and histone deacetylase (HDAC) to repress tran-
scription from the target loci (12, 13). On the other hand,
Polycomb complex 2 may include eed, Enx1 or Enx2,
Vav, HDAC, and YY1, a mammalian homologue of Pleio-
homeotic (14–17). HDAC may constitute the repressive
domain, while zeste and YY1 the DNA binding domain
(12, 13, 16, 17). There may be transition from PcG com-
plex 2 to 1 during development, which is suggested in early
 
Drosophila
 
 development (18).
As we previously reported 
 
rae28
 
-deficient mice (
 
rae28
 
 
 
/
 
 
 
)
displayed abnormal anteroposterior patterning in the skele-
tons and rhombomeres, which is reflected in altered 
 
Hox
 
gene expression in the maintenance phase (19, 20). The
similar abnormal anteroposterior patterning of the skeletons
was observed in mutant mice deficient in the other mam-
malian 
 
Pc
 
G genes, 
 
M33
 
, 
 
bmi1
 
, and 
 
mel18
 
 genes (21–24), in-
dicating that 
 
Pc
 
G are conserved in the function as well as in
the structure. Interestingly, studies of all the mutant mice
deficient in one of 
 
Pc
 
G showed that 
 
Pc
 
G have an important
function in lymphopoiesis (19, 21, 23, 25–28). B cell matu-
ration was arrested between the pro- and preB cell stages in
 
bmi1
 
-, 
 
mel18
 
-, 
 
M33
 
-, and 
 
rae28
 
-deficient mice and T cell
development was also impaired in some of these mice,
while preB lymphoid progenitors increased in 
 
eed
 
 mutant
mice and lymphoproliferative disorders appeared in the
later stages of the mutants (29). Although evidence has
been presented that 
 
bmi1
 
 and 
 
eed
 
 respectively act as positive
and negative regulators of the proliferative activity of lym-
phohematopoietic cells (29), the role of 
 
Pc
 
G in hemato-
poiesis has not been well characterized.
Accumulating evidence suggests that self-renewal and
commitment of hematopoietic stem cells (HSCs) to a distinct
lineage is governed by complex external signals that modu-
late gene expression patterns through activation of specific
transcription factors (30). However, much less is known
about the intrinsic genetic factors regulating HSCs (31). In
this context, 
 
Pc
 
G have recently attracted attention (6).
In this study, since 
 
rae28
 
 
 
/
 
 
 
 were lethal at the perinatal
period, we performed detailed examinations of hemato-
poiesis in 
 
rae28
 
 
 
/
 
 
 
 
 
embryos and provided in vivo as well as
in vitro evidence indicating that HSC activity is not suffi-
cient to maintain hematopoiesis in 
 
rae28
 
 
 
/
 
 
 
 during embry-
onic development. These findings strongly suggest that 
 
Pc
 
G
have a crucial role in the regulation of HSCs.
 
Materials and Methods
 
rae28-deficient Mice.
 
The generation of mice deficient in 
 
rae28
 
by homologous recombination has been described previously.
Neonates and embryos obtained by the Cesarean sections were
analyzed by PCR to identify the genotype and were subjected to
further hematological examinations (19).
 
Hematological Analysis of Peripheral Blood and Spleen Cells.
 
The
peripheral blood of embryos was obtained by heart puncture and
the counts were determined using hemocytometer. Cell suspen-
sions from the spleen were prepared using metal mesh. Manual
differential leukocyte counts of the blood cells were performed
on smears or cytocentrifuge preparations stained with May-Grün-
wald-Giemsa.
 
Methylcellulose Assay.
 
To detect myeloid colony-forming
cells (colony-forming units culture [CFU-Cs])
 
 
 
including ery-
throid CFU (CFU-E), erythroid burst-forming units (BFU-E),
granulocyte/macrophage CFU (CFU-GM) and multilineage
CFU (CFU-Mix), fetal liver cells were suspended in MethoCult
M3230 (Stem Cell Technologies) supplemented with 3 U/ml
human erythropoietin (Chugai), 10 ng/ml mouse stem cell factor
(Genzyme), 10 ng/ml mouse GM-CSF, and 10 ng/ml mouse IL-3
(BD PharMingen), and then plated in 35-mm Petri dishes. Colo-
nies were scored after 14 d of incubation at 37
 
 
 
C in a humidified
incubator with 5% CO
 
2
 
 in air (32, 33).
 
Long-Term Culture-initiating Cell (LTC-IC) Assay.
 
Fetal liver
cells were suspended in the myeloid long-term culture media
(Methocult M5300; Stem Cell Technologies) containing 10
 
 
 
6
 
 M
freshly dissolved hydrocortisone sodium hemisuccinate (Sigma-
Aldrich) and placed on S17 feeder layer in 60-mm Petri dishes.
Cultures were incubated at 33
 
 
 
C in humidified incubator with
5% CO
 
2
 
 in air and fed weekly by half-media exchange. The cul-
tures were recovered by exposure to 0.25% trypsin solution in
EDTA for 5 min. The cells were washed once and were assayed
for the presence of myeloid CFU-Cs (33, 34).
 
Day 12 CFU-Spleen (CFU-S
 
12
 
) Assay.
 
The day 12 CFU-
spleen (CFU-S
 
12
 
) content of cell suspensions was determined as
described originally. Appropriate dilutions of cells were injected
into congenic recipients that has been irradiated with 9.0 Gy
given in a single dose from a 
 
137
 
Cs 
 
 
 
-ray source. The spleen was
excised 12 d later, fixed in Telleyesniczky’s solution, and macro-
scopic surface colonies were counted (32, 35).
 
Long-Term Reconstitution Assay.
 
C57BL/6 mice were used as
recipients. The fetal liver cells (4 
 
 
 
 10
 
5
 
) were injected into
lethally irradiated recipient mice and their survival was moni-
tored. To quantitatively measure competitive repopulating units
(CRUs) test cells were prepared from 14.5-d post coitus (dpc) fe-
tal liver genetically labeled by EGFP. Lethally irradiated recipi-
ents were cotransplanted with the test cells and 10
 
5
 
 competitor
cells from the bone marrow of normal congenic mice. Reconsti-
tution by the test HSCs was assessed for each recipient 3 mo after
transplantation by analysis of peripheral blood. Peripheral blood
was obtained by retroorbital sinus puncture. Animals showing
 
 
 
1% of EGFP
 
 
 
-multilineage cells 3 mo after transplantation, as
determined by two-color FACS
 
®
 
 analysis with mAbs against
Gr-1, Mac-1, B220, and CD3 (BD PharMingen), were consid-
ered to be positive for repopulation by the test HSCs. The fre-
quency of CRUs in the test cells was determined by limiting
dilution analysis. A line of best fit was generated by the maximal-
likelihood method, and the frequency of CRUs determined using
standard statistical methods by interpolation of the number of test
cells required to obtain a 37% negative response (36, 37).
For serial bone marrow transplantation, EGFP-labeled fetal
liver cells containing predetermined number of CRUs were in-
jected into lethally irradiated first recipient mice. Secondary
transplantation was performed 1 mo after the primary transplanta-
tion to estimate expansion of CRUs in the primary recipients.
Increasing number of bone marrow cells from the primary recip-
ients were coinjected with competitor bone marrow cells. Ani-
mals showing both EGFP
 
 
 
-lymphoid and myeloid cells at a fre-
quency of 
 
 
 
1% were considered to be repopulated by CRUs
present in the primary recipients as described above. Expansion of
CRUs in the primary recipients was calculated by CRU fre-
quency in the recipients, which was estimated by limiting dilu-
tion analysis described above.
 
FACS
 
®
 
 Analysis.
 
Single cell suspensions of the fetal liver and
bone marrow were incubated with specific mAbs to murine cell 
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surface antigens: Mac-1, Gr-1, Ter-119, CD3, CD4, CD8, B220,
Sca-1, and c-kit (BD PharMingen). The antibodies were directly
coupled to FITC or biotin, the latter being visualized with
R-phycoerythrin-streptoavidin. Analysis was performed on a
FACSCalibur™ (Becton Dickinson) and dead cells were ex-
cluded by PI (1 
 
 
 
g/ml) staining and gating forward angle and side
scatter of light (25).
 
Preparation of Subpopulations of Hematopoietic Cells.
 
10–14-wk-
old C57BL/6 mice and 14.5 dpc embryos were dissected to ob-
tain bone marrow and fetal liver cells. These cells were pooled,
washed twice with PBS, made into single-cell suspension by re-
peating pipetting, and filtered through 40-
 
 
 
m nylon mesh. Cells
reacting to antibodies against Gr-1, B220, CD4, CD8, and Ter-
119 were removed by using immunomagnet beads. The result-
ing Lin
 
 
 
 cells were stained with FITC-conjugated anti–Sca-1
antibodies. Cell sorting was performed on a FACSVantage™
(Becton Dickinson), to purify Lin
 
 
 
 Sca-1
 
 
 
 and Lin
 
 
 
Sca-1
 
 
 
 frac-
tions.
 
Cell-Cycle Analysis.
 
Cells were pulse labeled with bromode-
oxyuridine (BrdU) (Sigma-Aldrich) at 10 
 
 
 
g/ml for 15 min at
37
 
 
 
C, harvested, washed with PBS, and fixed in cold 70% etha-
nol. Cells were treated with 1 mg/ml RNase at 37
 
 
 
C for 20 min.
Cells were subjected to ice-cold 0.1 M HCl for 10 min. The
washed cells were heated to 95
 
 
 
C. The tubes were suspended in
ice-cold PBS containing 0.5% Tween 20 (PBST). The cells were
stained with anti-BrdU antibody (BD PharMingen) diluted 1:100
in PBST containing 0.5% BSA at room temperature for 30 min.
After washing twice with PBST, the cells were stained in 0.4 ml
FITC-conjugated goat anti–mouse IgG antibody (BD PharMin-
gen) diluted 1:100 in PBST containing 0.5% BSA. After 20 min
the cells were washed and resuspended in PBS containing 10 
 
 
 
g/
ml PI to stain DNA. Cells were analyzed on a FACSCalibur™
(reference 38; Becton Dickinson).
 
Total cDNA Amplification and Southern Blot Analysis of the
cDNA.
 
Total cellular RNAs were extracted from fetal liver cells
and purified hematopoietic cells by the acid guanidinium thiocy-
anate-phenol-chloroform method. cDNA was synthesized with a
60-mer primer containing a polythymidine stretch. A short poly-
adenosine tail was added to the first strand of the cDNA using
terminal deoxynucleotidyltransferase (GIBCO BRL). Second-
strand synthesis and PCR amplification were done with the same
primers. Amplified total cDNA was size fractionated on a 1% aga-
rose gel, transferred to nylon membranes, and subsequently hy-
bridized with 
 
32
 
[P]-labeled probes (39).
 
Results
 
Expression of rae28 in Hematopoietic Cells.
 
As we re-
ported previously, expression of 
 
rae28
 
 is predominant in the
embryonic stage and almost disappears after birth except for
the genital organs, brain, and thymus (4). We performed
detailed examinations of 
 
rae28
 
 expression in the hematopoi-
etic organs and subpopulations of the fetal liver and bone
marrow cells. Total cellular RNAs were extracted from the
fetal liver, spleen, thymus, and from the FACS
 
®
 
-purified
subpopulations of the fetal liver and bone marrow cells.
PCR-amplified total cDNAs were generated from mRNAs
extracted from these organs and subpopulations, and it was
confirmed that the amplified cDNAs preserved quantitative
differences in mRNA abundance (data not shown).
 The amplified cDNAs were subjected to Southern blot
hybridization for analysis of 
 
rae28
 
 expression. This expres-
sion was detected in abundance in the fetal liver at 12.5 and
14.5 dpc, while it decreased at 18.5 dpc and was undetect-
able in the adult liver probably due to emigration of the he-
matopoietic cells (Fig. 1). 
 
rae28
 
 expression levels were much
higher in the Lin
 
 
 
 Sca-1
 
 
 
 subpopulation enriched for prim-
itive hematopoietic cells including HSCs than in the whole
fetal liver and bone marrow cells (Fig. 1). It should be noted
that a relatively high expression of 
 
rae28
 
 was preserved in
the HSC-enriched subpopulation of the hematopoietic cells.
 
Hematological Examination of the Peripheral Blood Cells and
Spleen.
 
The hematological findings for the peripheral
blood showed no significant differences in myeloid and
erythroid lineages in 
 
rae28
 
 
 
/
 
 
 
 neonates, although lymphoid
cells tended to be reduced (Fig. 2 A). No significant differ-
ences were also observed in the 10.5-dpc primitive eryth-
rocytes, peripheral blood and fetal liver cells at the cytolog-
ical level (data not shown). The spleen in 
 
rae28
 
 
 
/
 
 
 
neonates was hypoplastic, although the severity varied
among individuals (Fig. 2 B). The number of nucleated
cells was reduced to 12.5% of the wild-type in the spleen of
the mutant neonates (data not shown) but cell numbers
were not reduced in the fetal liver. FACS
 
®
 
 analysis of the
spleen cells showed a reduction in B cells, but cells with the
other lineage markers were conserved (data not shown).
Figure 1. Expression of rae28 in hematopoietic tissues
and purified subpopulations of fetal liver and bone marrow
cells. PCR-amplified total cDNAs were prepared from to-
tal RNAs extracted from the hematopoietic tissues and
fractionated cells and were analyzed by Southern blot
analysis with a rae28 probe. Note that high rae28 expression
was detected in Lin , Sca-1  subpopulations. BM, bone
marrow; FL, fetal liver; Whole, whole fetal liver or bone
marrow cells; Lin , Sca-1 , Lin , Sca-1  subpopulations
of fetal liver and bone marrow cells. Expression of  -actin
is shown to confirm equal amount of cDNA on the filter. 
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Expansion of CFU-C and CFU-S
 
12
 
 during Embryonic De-
velopment.
 
Splenic hypoplasia and the reduced number of
spleen cells described above suggested the presence of
hematopoietic defects in 
 
rae28
 
 
 
/
 
 
 
 embryos, because the
spleen is one of the major hematopoietic organs in the neo-
natal period. We first examined the increase in CFU-Cs
during fetal development. Although clonogenic progeni-
tors including CFU-Mix, CFU-GM, CFU-E, and BFU-E
were generated and increased until 14.5 dpc in 
 
rae28
 
 
 
/
 
 
 
embryos, expansion of all these hematopoietic progenitors
was impaired later in the fetal development (Fig. 3 A). We
next examined more premature hematopoietic progenitors
in 
 
rae28
 
 
 
/
 
 
 
 embryos, and found that CFU-S
 
12
 
 was mark-
edly reduced in number to one-tenth of the normal level as
early as 12.5 dpc and expansion of CFU-S
 
12
 
 was affected
during embryonic development (Fig. 3 B). The size of
CFU-S
 
12 
 
colonies was also significantly reduced in 
 
rae28
 
 
 
/
 
 
 
(Fig. 3 C).
 
LTC-IC Assay.
 
Activity of HSCs in the mutants at
14.5 dpc was examined in vivo as well as in vitro. First, we
performed the LTC-IC assay. In this assay we determined
the number of clonogenic progenitors in fetal liver cells
cultured on an S17 feeder layer for 2–3 wk. Although the
limiting dilution assay to determine the frequency of LTC-
IC was not performed, the number of CFU-C colonies can
be assumed to reflect the frequency and proliferative capac-
ity of LTC-IC on the feeder layer. The reduction in the
number of colonies was evident in 
 
rae28
 
 
 
/
 
 
 
 (Fig. 3 D).
The number was reduced more remarkably in 3-wk than
in 2-wk cultured fetal liver cells, suggesting that reduction
of LTC-IC is more prominent in the upper level of the he-
matopoietic hierarchy in 
 
rae28
 
 
 
/
 
 
 
.
 
Long-Term Reconstitution Assay.
 
The most rigorous test
of the function of HSCs is the ability to reconstitute the
hematopoietic system of recipients in which endogenous
hematopoiesis has been ablated. Since the methylcellulose
clonogenic, CFU-S
 
12
 
 and LTC-IC assays showed reduc-
tion of premature hematopoietic cells in 
 
rae28
 
 
 
/
 
 
 
 as men-
tioned earlier, we assessed the ability of the fetal liver cells
to reconstitute the hematopoietic system in lethally irradi-
ated mice. The fetal liver cells (4 
 
 
 
 10
 
5
 
) from 14.5 dpc
wild-type and 
 
rae28 /  embryos were injected into lethally
irradiated congenic recipient mice and their survival was
monitored. All the recipients injected with rae28 /  fetal
Figure 2. Peripheral blood cells and the spleen. (A) Peripheral blood
cell counts. The data represent mean values with a SD from at least three
independent individuals. (B) Picture of spleen from  / , wild-type and
 / , rae28 /  mice.763 Ohta et al.
liver cells died within 3 wk, while 70% of those with wild-
type cells survived  12 wk, indicating that the ability to
reconstitute the hematopoietic system was severely reduced
in rae28 /  fetal liver cells (Fig. 4).
Quantitative measurement of CRUs by limiting dilution
analysis was then performed to allow direct comparison of
the frequency and activity of HSCs. First, we intercrossed
rae28 /  heterozygous mice with a transgenic line ubiqui-
Figure 3. (A) Expansion of CFU-Cs during embryonic
development. The number of CFU-Cs in the embryonic fe-
tal liver from 12.5 to 18.5 dpc was examined by methylcellu-
lose assay. The data represent the mean number of CFU-Cs
with a SD from at least five individuals. Both BFU-E and
CFU-E are shown as erythroid colonies. Note that expan-
sion of CFU-Cs including CFU-mix, CFU-GM, and
BFU-E/CFU-E was progressively impaired in rae28 / 
embryos after 14.5 dpc. Black squares, wild-type; black cir-
cles, rae28 / . (B) Expansion of CFU-S12 during embryonic
development. The data represent the mean of CFU-S12 col-
ony numbers with a SD determined from a minimum of
five recipients. The magnified panel shows the number of
CFU-S12 in 12.5 dpc fetal liver cells. The number of CFU-S12
was already reduced at 12.5 dpc and its expansion during fetal
development was also less effective in rae28 / . Black
squares, wild-type; black circles, rae28 / . (C) Picture of
CFU-S12 colonies. Fetal liver cells (4   105) were injected to
sublethally irradiated mice and the number of CFU-S12 was
counted after fixation with Telleyesniczky’s solution. The
size as well as the number of CFU-S12 colonies was reduced in rae28 / .  / , wild-type;  / , rae28 / . (D) The number of LTC-IC in the 14.5 dpc
fetal liver. Fetal liver cells were cultured 2 and 3 wk on S17 feeder layer cells and cultured cells were subjected to methylcellulose assay. The data repre-
sent the mean of CFU-C colony numbers with a SD determined from at least five individuals. The number is presumed to reflect the frequency and ex-
pansion of LTC-IC during the culture. Note that the reduction of LTC-IC was more severe in 3-wk culture than in 2-wk culture. White squares, wild-
type; black squares, rae28 / .764 A Role of rae28 in Hematopoiesis
tously expressing EGFP (40) and prepared rae28 /  ho-
mozygous and wild-type embryos expressing EGFP to dis-
tinguish the test cells from the competitors. Increasing
doses of fetal liver cells from the EGFP-labeled 14.5 dpc
rae28 /  and wild-type embryos were mixed with 105
wild-type bone marrow cells as competitors and trans-
planted into lethally irradiated congenic recipients. Limit-
ing dilution analysis revealed  20-fold reduction in CRU
frequency in rae28 /  compared with the wild-type (1 per
4   105 vs. 1 per 2   104, respectively, P   0.01; Fig. 5
A). Thus total numbers of CRUs in the rae28 /  and wild-
type fetal liver were estimated to be 50 and 1,000, respec-
tively, because the number of fetal liver cells was 2   107
in either of rae28 /  and wild-type.
Serial Transplantation Experiment. To further assess the
self-renewal ability of rae28 /  HSCs, we performed serial
transplantation experiments. Fetal liver cells containing 20
CRUs, as calculated in terms of the frequency of CRUs
determined as described above, were transplanted into le-
thally irradiated primary recipient mice. 1 mo after trans-
plantation, bone marrow cells from the femurs and tibias of
the primary recipient mice were assayed for CRU number
by limiting dilution analysis in secondary recipients. The
frequency of CRUs was 1 per 2   105 cells in primary re-
cipients reconstituted with wild-type CRUs (Fig. 5 B)
compared with 1 per 3   106 in those with rae28 /  (Fig.
5 C), indicating a markedly impaired regenerative capacity
for CRUs in the absence of rae28 (Table I). The number of
total bone marrow cells was 2.4   107 in the femurs and
tibias of primary recipients reconstituted with either the
wild-type or rae28 /  CRUs. Since bone marrow cells in
the femurs and tibias are estimated to correspond to 18.7%
of total marrow cells (41), 1 mo after reconstitution the
numbers of CRUs in the total marrow of primary recipi-
ents reconstituted with the wild-type and rae28 /  CRUs
were  640 and 43, respectively. The increase in CRUs
was estimated to be 32 times within 1 mo in the wild-type,
but that in rae28 /  was, surprisingly, limited to no more
than 2.2 times (Table I). These in vivo results clearly dem-
onstrated that the self-renewal ability of CRUs was se-
verely impaired in rae28 / .
Cell-Cycle Analysis of Fetal Liver Cells. To examine
whether hematopoietic defects in the rae28 /  fetal liver
reflected an impaired proliferation of fetal liver cells, we
examined the cell cycle status of 14.5 dpc fetal liver cells.
The relative DNA content of the fetal liver cells was as-
sessed with PI staining, whereas BrdU incorporation by the
cells was measured after in vitro BrdU pulse labeling for 1 h
of the isolated cells. As shown in Fig. 6, no significant dif-
ference in cycling parameters was evident.
Expression of Genes Involved in Hematopoiesis. To iden-
tify possible downstream target genes causing the HSC de-
fects in rae28 / , we analyzed the expression of Hox and
genes which could potentially be involved in hematopoie-
sis. Total cDNAs were synthesized from mRNAs extracted
from fetal liver cells at 14.5 dpc, which proved to predom-
inantly consist of hematopoietic cells ( 95%; data not
shown) and Hox expression was detected by Southern blot
analysis. We focused on a- and b-clustered Hox genes
which are suspected to be involved in myelopoiesis. Al-
though the expressions of Hoxa1, a2, a3, a4, a7, a9, a10,
b1, b2, b3, b4, b5, and b8 were all examined, no significant
differences in the expression levels of these genes could be
detected (Fig. 7 A).
We similarly analyzed expression levels of representative
receptors and transcription factors which are involved in
hematopoiesis in the mutant fetal liver, including gp130,
Epo receptor, G-CSF receptor, GM-CSF receptor, c-erbA ,
c-Mpl, c-jun, c-fos, c-myc, c-myb, tal1/SCL, AML1, GATA1,
GATA2, and PU.1. Expression of none of these genes was
found to have significantly changed in the rae28 /  fetal
liver cells (Fig. 7 B). We also examined expression of the
ink4a-ARF genes (p16ink4A and p19ARF), p21 CDK inhibi-
tor, B-raf, bax, and Ubiquitin genes. No significant differ-
ences could be detected in the expression of these genes in
the rae28 /  fetal liver (Fig. 7 B). ink4a-ARF gene prod-
ucts were further detected by Western blot analysis to con-
firm the findings (data not shown).
Figure 4. Kaplan-Meier survival curve of lethally irradi-
ated congenic mice transplanted with fetal liver cells. Fetal
liver cells (4   105) prepared from 14.5-dpc embryos were
injected into congenic recipient mice and survival of the
mice was investigated in the conventional facility. Black
squares, wild-type; black circles, rae28 / .765 Ohta et al.
Discussion
We have previously shown that rae28 is involved in the
early stage of B cell differentiation in a gene dosage–depen-
dent manner (25). rae28 is, however, predominantly ex-
pressed during early ontogeny (4) and rae28 expression is
preserved at high levels even in the adult stage in cell pop-
ulations that are enriched in HSCs (Fig. 1). The detailed
analysis of premature hematopoietic cells including HSCs
in rae28 /  reported here reveals a crucial role for rae28 in
sustaining HSC activity. Fetal liver cellularity and mature
cell components were, however, relatively conserved in
rae28 / , probably because premature hematopoietic cells,
although limited in number, can compensate for the reduc-
Figure 5. Competitive repopulation assay. (A) Fre-
quency of CRUs in the fetal liver. The peripheral blood
cells in the congenic recipient mice injected with 14.5-dpc
fetal liver cells were examined to assess the long-term re-
constitution capacity of HSCs. 3 mo after transplantation,
the proportion of mice exhibiting  1% EGFP  cells was
used to calculate the frequency of CRU. Black squares,
wild-type; black circles, rae28 /  (B and C) Serial trans-
plantation experiments. Lethally irradiated recipient mice
were injected with fetal liver cells including 20 CRUs, and
1 mo after injection frequency of CRUs in the primary re-
cipient mice was determined by CRU assay. Frequency of
CRUs derived from the wild-type and rae28 /  cells was
calculated from Figs. B and C, respectively. Note the
number of injected cells shown in the top column of the
figures is 10 times different between Figs. B and C.766 A Role of rae28 in Hematopoiesis
tion. The progressive reduction of clonogenic progenitors
may thus be compatible with functional failure of HSCs to
supply the progenitors. The number of CRUs in rae28 / 
was only one-twentieth of the wild-type (1 per 4   105
cells) (Fig. 5 A), suggesting that no more than 50 CRUs
were generated in the rae28 /  fetal liver during the devel-
opmental period. Furthermore, rae28 /  CRUs underwent
a net expansion of no more than 2.2-fold in transplant re-
cipients in 1 mo, while wild-type CRUs expanded 32-fold
(Table I), indicating that the transplanted rae28 /  CRUs
were amplified much less efficiently under the conditions
of this assay.
Although we could not determine whether wild-type
HSCs can reconstitute the hematopoietic system in rae28 / 
mice because rae28 /  embryos were lethal at the perinatal
period, the result of a series of reconstituting experiments
described in this study suggests that HSC defects in rae28 / 
are manifest within the HSC population rather than in the
nonhematopoietic accessory cells of fetal liver and spleen.
This is also supported by the evidence that a secondary
CFU-S12 assay with wild-type congenic recipients demon-
strated a reduction in the self-renewal ability of rae28 / 
CFU-S12 (data not shown). The reduced activity of rae28 / 
HSCs is presumed to be at least in part responsible for the
poor expansion of CFU-S12 and the progressive reduction
of clonogenic progenitors during fetal development. How-
ever, the size of CFU-S12 was significantly reduced and
their self-renewal ability was diminished in the secondary
CFU-S12 assay as described earlier, suggesting that the
progenies derived from rae28 /  HSCs were also affected
in their ability. 
Thus, abrogated HSCs thus appear to cause a systemic
defect in the hematopoietic system in rae28 / , which can
be expected to result in hyposplenia in rae28 /  neonates.
Our study supports the notion that rae28 is indispensable
for sustaining the activity of HSCs. The function of rae28
in anteroposterior patterning of the rhombomeres and
paraxial mesoderm is mediated by its sustaining effect on
Hox expression once initiated (19). Expression of multiple
Hox genes from the three different clusters (Hoxa3, a4, a5,
b3, b4, and d4) was found to be affected in the paraxial
mesoderm of rae28 /  embryos and that of Hoxb3 and b4
was also affected in the rhombomeres during the mainte-
nance phase (19, 20). Since Hox overexpression results in
myelo- or lymphoproliferation (42–46), we examined the
effect of rae28 deficiency on the expression of Hox genes
in the a and b clusters in the fetal liver cells, because these
Hox genes are expressed in the myeloid cells (47). How-
ever, none of the Hox genes examined showed significant
differences in their expression in rae28 /  fetal liver cells
(Fig. 7 A).
We further analyzed expression of representative cyto-
kine receptors (gp130, Epo receptor, G-CSF receptor, GM-
CSF receptor, c-erbA , and c-Mpl), transcription factors
(c-jun, c-fos, c-myc, c-myb, tal1/SCL, AML1, GATA1,
GATA2, PU.1, and Ikaros; unpublished data), a tumor sup-
pressor (p19) and a cyclin-dependent kinase inhibitor (p16
and p21) in the rae28 /  fetal liver. gp130, a common sig-
nal transducer of LIF, IL-6, and oncostatin M, and c-MPL,
a receptor for thrombopoietin, are assumed to have an im-
portant function in inducing self-renewal of HSCs (48–50).
Table I. Semiquantitative Analysis of Self-Renewal Ability
of CRUs
Genotype  /   / 
Injected CRUs 20 20
BM cells in the femurs and tibias 2.4   107 2.4   107
Frequency of CRUs 1/2   105 1/3   106
CRUs in the femurs and tibias 120 8
CRUs in the entire body 640 43
Increase of CRUs 32  2.2 
The numbers of bone marrow cells and CRUs in the primary recipients
were examined one month after transplantation. The numbers of bone
marrow cells represent mean values from four independent individuals.
Frequency of CRUs was estimated by competitive repopulating unit
assay shown in Figure 5.   The numbers of CRUs in the entire body
were calculated based on the previous report that bone marrow cells in
the femurs and tibias correspond to 18.7 % of those in the entire body.
BM, bone marrow; +/+, wild-type;  / , rae28 / .
Figure 6. Cell cycle status of fetal liver
cells. Cells were pulse-labeled with 10  g/
ml BrdU after harvest, stained with PI, and
subjected to FACS® analysis. Representa-
tive BrdU-FITC/PI fluorescence profiles of
wild-type and rae28 /  fetal liver cells are
shown in the Figure.  / , wild-type;  / ,
rae28 / .767 Ohta et al.
c-kit, a receptor for SCF, synergizes with other cytokines to
promote the formation of all lineages from HSCs (51). Ex-
aggerated expression of p16 and p19 has been reported to
cause abnormal lymphopoiesis in mutant mice overexpress-
ing and lacking bmi1 (52, 53), and p21 has been shown to
play a part in governing the entry of HSCs into the cell cy-
cle (54). However, our study did not detect any signifi-
cantly altered expressions of mRNAs for these molecules in
rae28 /  fetal liver cells (Fig. 7 B). FACS® analysis con-
firmed that there were no differences in c-kit, sca-1, and IL-
7R  expression in the fetal liver cells (data not shown).
These findings strongly suggest that development of he-
matopoietic cells with the lineage markers is well conserved
in the rae28 /  fetal liver and that the affected cells are re-
stricted to a small subpopulation of premature hematopoi-
etic cells including HSCs. While it is not likely that abnor-
mal expression of these genes mediates the functional
defects of HSCs in rae28 / , we cannot exclude the possi-
bility that rae28 deficiency affects expression of the genes
exclusively in the specific subpopulations of hematopoietic
cells such as HSCs. Furthermore, TUNEL staining could
not detect increased apoptosis in the 14.5 dpc fetal liver
from rae28 /  (data not shown) and cell cycle status of
rae28 /  fetal liver cells remained unaffected at 14.5 dpc
(Fig. 6). Although compensatory mechanisms might pre-
serve cell cycling, it is also unlikely that defective hemato-
poiesis in rae28 /  resulted from abnormal cell cycling and
apoptosis in fetal liver cells.
To determine whether the hematopoietic defects in
rae28 /  resulted from a defect in the development of
HSCs, we examined hematopoiesis in the early stage of de-
velopment. Histoanatomical examinations showed no sig-
nificant abnormalities in primitive hematopoiesis in the
rae28 /  yolk sac (data not shown). Since we could not de-
tect CFU-S12 even in the wild-type aorta-gonad-meso-
nephros region, development of premature hematopoietic
cells in rae28 /  embryos at 10.5 dpc remains uncharacter-
ized. CFU-S12 was, however, already reduced in the 12.5
dpc fetal liver of the mutants and CRUs were remarkably
underdeveloped at 14.5 dpc (Fig. 3 B). Although it appears
Figure 7. Expression of a- and
b-clustered Hox genes (A) and genes
for receptors, signaling molecules
and transcription factors (B) in-
volved in hematopoiesis. Expression
of the p16, p19, and p21 genes were
also shown in the Figure. PCR-
amplified total cDNAs were pre-
pared from 14.5 dpc fetal liver cells
and expression of the genes was ana-
lyzed by Southern blot analysis. Ex-
pression of  -actin is shown as an in-
ternal marker to confirm the equal
amount of cDNAs on the filter.
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difficult to make a clear distinction as to whether or not
rae28 deficiency affects the development of HSCs, we de-
tected CRUs, even at a low frequency, in the rae28 /  fe-
tal liver. These CRUs were able to reconstitute the he-
matopoietic system by producing multilineage mature
blood cells for  3 mo in the congenic recipients. Thus, it
can be assumed that rae28 is not essential for the develop-
ment of HSCs but is required for sustaining the HSC activ-
ity for the amplification of HSCs after they are developed.
eed and bmi1 were shown to regulate the proliferative ac-
tivity of the mature and premature hematopoietic progeni-
tors in, respectively, a positive and negative manner (29).
However, HSCs were reported to be unaffected critically
in bmi1-deficient mice, because erythropoiesis was not al-
tered (23). The hematopoietic defect in bmi1-deficient
mice was explained by the hypothesis that parallel pathways
exist to compensate for the lack of bmi1 in the fetal period
and that the hematopoietic disorder becomes overt later on
after the disappearance of the compensatory pathway (23).
And another explanation of the hematopoietic defects was
that it results from progressive overexpression of p16 CDK
inhibitor from the ink4A-ARF locus (52). Abnormal ex-
pression of p16 and p19 from the ink4A-ARF locus, how-
ever, was not detected in rae28 /  fetal liver cells and im-
paired activity of HSCs is assumed to result in inefficient
hematopoiesis during fetal development of rae28 / . Since
expression levels of transcription factors regulating lineage
determination and those of lineage specific genes are con-
served as far as we examined in this study, differentiation
potential of HSCs seem to be relatively conserved except
for B cell differentiation (25). The defect appears to be
mainly focused on self-renewal ability of HSCs, which in-
volves regulation of the cell cycle machinery and mainte-
nance of the pluripotency.
Because PcG complex 1 appears to consist of multiple
complexes varying in the constituents (6), that may reflect
the functional specificity, each of the PcG members may
display a different specific function in hematopoiesis. It is
now possible to speculate about some plausible mechanisms
underlying HSC defects in rae28 /  embryos. First, a PcG
complex with rae28 may play a part in maintaining the re-
pressive state of genes which preserves the activity of
HSCs, i.e., transcription of genes crucial for regulation of
proliferation, commitment, and apoptosis of HSCs may be
dysregulated, causing dysfunction of HSCs. This assump-
tion is highly compatible with the expression profile of
rae28, which shows that high rae28 expression in primitive
hematopoietic cells is progressively reduced in the course
of hematopoietic cell differentiation. Second, since B cell
defects in mice deficient in PcG family members are known
to result at least partly from unresponsiveness to IL-7 (23,
25, 27), it may be possible that rae28 /  HSCs show no re-
sponse or a poor response to cytokines crucial for the regu-
lation of HSCs. In any case, since PcG-mediated repression
system is presumed to play a crucial part in the regulation
of HSCs, rae28 /  mutant mice can be expected to facili-
tate the clarification of molecular mechanisms underlying
the regulation of HSCs.
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